Search

everythinglearnresearchcommunity

for

Search:↓

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

PRP injections did not significantly improve hair growth in men with androgenetic alopecia.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Trichoscopy helps diagnose female hair loss easily.

People with androgenetic alopecia have a higher risk of heart disease.

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Topical melatonin is a safe treatment that may reduce hair loss in people with androgenetic alopecia.

The herbal mix (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) and the 3% Minoxidil solution are equally effective in treating hair loss, but the herbal mix has fewer side effects.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Stem cell treatment improved life quality and sexual function in women with hair loss.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Men with a family history of hair loss on their mother's side are more likely to have female pattern hair loss.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

Low PON1 levels may indicate and predict the severity of hair loss.

Patients and doctors often differ in assessing hair loss severity, so treatment should be personalized.

COVID-19 may worsen hair loss, but treatments like minoxidil can help.

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

Combining microneedling with light therapy increased hair density by 26% in men.

The combination of oral finasteride and dutasteride with topical minoxidil effectively promotes new hair growth in most people, with minimal side effects.

Women with androgenetic alopecia have lower zinc and iron levels.